Candriam SCA’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-149,466
| Closed | -$1.55M | – | 890 |
|
|
2020
Q1 | $1.55M | Buy |
149,466
+28
| +0% | +$291 | 0.02% | 581 |
|
|
2019
Q4 | $1.59M | Buy |
149,438
+35,438
| +31% | +$377K | 0.02% | 598 |
|
|
2019
Q3 | $1.19M | Buy |
114,000
+34,000
| +43% | +$354K | 0.02% | 578 |
|
|
2019
Q2 | $1.22M | Buy |
+80,000
| New | +$1.22M | 0.02% | 612 |
|
|
2017
Q1 | – | Sell |
-244,000
| Closed | -$2.61M | – | 716 |
|
|
2016
Q4 | $2.61M | Sell |
244,000
-13,000
| -5% | -$139K | 0.06% | 316 |
|
|
2016
Q3 | $2.78M | Buy |
+257,000
| New | +$2.78M | 0.07% | 294 |
|